Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$4.97 - $7.7 $50,957 - $78,948
-10,253 Closed
0 $0
Q3 2019

Nov 15, 2019

SELL
$5.11 - $5.99 $128,245 - $150,331
-25,097 Reduced 71.0%
10,253 $55,000
Q2 2019

Aug 15, 2019

BUY
$5.39 - $6.26 $190,536 - $221,291
35,350 New
35,350 $195,000

Others Institutions Holding KMDA

About KAMADA LTD


  • Ticker KMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 44,800,500
  • Market Cap $271M
  • Description
  • Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...
More about KMDA
Track This Portfolio

Track Engine Capital Management, LP Portfolio

Follow Engine Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engine Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Engine Capital Management, LP with notifications on news.